Melbourne researchers have shown a type of leukaemia can be successfully ‘reversed’ by coaxing the cancer cells back into normal development.
The discovery was made using a model of B-progenitor acute lymphoblastic leukaemia (B-ALL), the most common cancer affecting children.
Researchers from the Walter and Eliza Hall Institute showed that switching off a gene called Pax5 could cause cancer in a model of B-ALL, while restoring its function could ‘cure’ the disease.
Institute researchers Dr Ross Dickins and Ms Grace Liu led the study with institute colleagues and collaborators in Vienna. The study was published today in the journal Genes & Development.
Ms Liu said the team used a newly developed ‘genetic switch’ technology to inhibit then reactivatePax5 in the leukaemia model.
“Along with other genetic changes, deactivating Pax5 drives normal blood cells to turn into leukaemia cells, which has been shown before,” Ms Liu said. “However we showed for the first time that reactivating Pax5 enabled the cells to resume their normal development and lose their cancer-like qualities, effectively curing the leukaemia. What was intriguing for us was that simply restoring Pax5 was enough to normalise these cancer cells, despite the other genetic changes.”
Read more . . .
The Latest on: Gene switch reverses cancer
[google_news title=”” keyword=”Gene switch reverses cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Gene switch reverses cancer
- Verdant Community Wellness Day: Using lifestyle medicine to reduce health riskson March 19, 2024 at 1:47 pm
This is the third of a three-part series summarizing Verdant Community Wellness Day presentations. You can read part 1, addressing domestic violence among ...
- Discovering the on-switch for rare genetic inflammatory diseaseson March 18, 2024 at 9:54 pm
University of Queensland researchers have discovered how the 'on-switch' for the body's inflammation machinery can get stuck and cause rare genetic inflammatory diseases. Professor Kate Schroder and ...
- Space-based research helps identify cancer ‘kill switch’on March 15, 2024 at 1:21 pm
President Joe Biden’s “cancer moonshot” hasn’t literally put cancer research on the moon. But research conducted on the International Space Station has yielded a major development: a cancer “kill ...
via Bing News